Wolfen Richard M. 4

Accession 0000899243-21-031833

CIK 0001111485other

View on SEC.gov Company Profile

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 7:51 PM ET

Size

49.5 KB

Accession

0000899243-21-031833

Insider Transaction Report

Form 4

Period: 2021-08-03

RxSight, Inc.RXST

Wolfen Richard M.

Director

Transactions

Conversion
Series F Preferred Stock
2021-08-03−154,886→ 0 total(indirect: See footnote)
→ Common Stock (235,499 underlying)
Conversion
Series H Preferred Stock
2021-08-03−157,709→ 0 total(indirect: See footnote)
→ Common Stock (157,709 underlying)
Exercise/Conversion
Warrant (right to buy)
2021-08-03−1,452→ 0 total
Exercise: $12.40From: 2017-02-24→ Series H Preferred Stock (1,452 underlying)
Conversion
Series E Preferred Stock
2021-08-03−4,840→ 0 total
→ Common Stock (5,887 underlying)
Conversion
Series G Preferred Stock
2021-08-03−357,227→ 0 total(indirect: See footnote)
→ Common Stock (357,227 underlying)
Conversion
Series E Preferred Stock
2021-08-03−18,150→ 0 total(indirect: See footnote)
→ Common Stock (22,077 underlying)
Conversion
Series A Preferred Stock
2021-08-03−2,800→ 0 total
→ Common Stock (2,800 underlying)
Conversion
Series B Preferred Stock
2021-08-03−2,017→ 0 total
→ Common Stock (2,017 underlying)
Conversion
Series B Preferred Stock
2021-08-03−246,054→ 0 total(indirect: See footnote)
→ Common Stock (246,054 underlying)
Conversion
Series D Preferred Stock
2021-08-03−10,807→ 0 total
→ Common Stock (12,586 underlying)
Conversion
Common Stock
2021-08-03+76,974→ 78,170 total
Conversion
Common Stock
2021-08-03+1,489,805→ 1,762,074 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2021-08-03−11,714→ 0 total(indirect: See footnote)
→ Common Stock (11,714 underlying)
Conversion
Series C Preferred Stock
2021-08-03−398,810→ 0 total(indirect: See footnote)
→ Common Stock (408,814 underlying)
Conversion
Series D Preferred Stock
2021-08-03−43,547→ 0 total(indirect: See footnote)
→ Common Stock (50,711 underlying)
Conversion
Series G Preferred Stock
2021-08-03−42,552→ 0 total
→ Common Stock (42,552 underlying)
Conversion
Series H Preferred Stock
2021-08-03−9,680→ 0 total
→ Common Stock (9,680 underlying)
Exercise/Conversion
Series H Preferred Stock
2021-08-03+1,452→ 1,452 total
Exercise: $12.40→ Common Stock (1,452 underlying)
Conversion
Series H Preferred Stock
2021-08-03−1,452→ 0 total
→ Common Stock (1,452 underlying)

Footnotes (11)

[F1]All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F10]The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F11]The number of shares of Series D Preferred Stock reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly allocated the number of shares directly and indirectly held.
[F2]Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares.
[F3]All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F4]All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F5]All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F6]All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F7]All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F8]All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
[F9]All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RxSight, Inc.

CIK 0001111485

→

Entity typeother

Related Parties

filerCIK 0001873830

Filing Metadata

Form type: 4
Filed: Aug 4, 8:00 PM ET
Accepted: Aug 5, 7:51 PM ET
Size: 49.5 KB

View on SEC.gov